Synthesis, crystal structure, and anticancer properties of cyclic monocarbonyl analogs of curcumin

Medicinal Chemistry Research

Volumn 20, Issue 1, 2011, Pages 81-87

  Karthikeyan, Natesan Sundarmurthy ^a   Sathiyanarayanan, Kulathu Iyer ^a   Aravindan, Paduthapillai Gopal ^a   Giridharan, P ^b  

^a VIT UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

Author keywords

1 Benzyl 4 piperidone; 2 Indanone; Aromatic aldehyde; Curcumin derivatives; Molecular docking

Indexed keywords

1 BENZYL 3,5 DIBENZYLIDENEPIPERIDIN 4 ONE; 1,3 BIS(2 METHOXYBENZYLIDENE)INDAN 2 ONE; 1,3 BIS(4 CHLOROBENZYLIDENE)INDAN 2 ONE; 1,3 BIS(4 METHOXYBENZYLIDENE)INDAN 2 ONE; 3,5 BIS(3 HYDROXYBENZYLIDENE) 1 BENZYLPIPERIDIN 4 ONE; 3,5 BIS(4 ALLYLOXYBENZYLIDENE) 1 BENZYLPIPERIDIN 4 ONE; 3,5 BIS(4 ETHOXYBENZYLIDENE) 1 BENZYLPIPERIDIN 4 ONE; 3,5 BIS(4 METHOXYBENZYLIDENE) 1 BENZYLPIPERIDIN 4 ONE; ANTINEOPLASTIC AGENT; CARBONYL DERIVATIVE; CURCUMIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL BOND; COLON CANCER; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PANCREAS CANCER; POWDER; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79952702017     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9284-7     Document Type: Article

References (24)

1. Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem 12:3871-3883. doi:10.1016/j.bmc.2004.05.006 (Pubitemid 38798249)
2. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363-398. doi:0250-7005/2003
3. Cell viability assessment was performed by using Cell Counting Kit (CCK-8), which was purchased from Dojindo Laboratory, Japan. Experiment design was guided by the CCK-8 technical manual available at http://www.dojindo.com/ newimages/CCK-8TechnicalInformation.pdf
4. Chandru H, Sharada AC, Kumar CSA, Rangappa KS (2008) Antiangiogenic and growth inhibitory effects of synthetic novel 1,5-diphenyl-1,4-pentadiene-3-one- 3-yl-ethanone pyridine curcumin analogues on Ehrlich ascites tumor in vivo. Med Chem Res 17:515-529. doi:10.1007/s00044-008-9095-2
5. Das U, Alcorn J, Shrivastav A, Sharma RK, De Clercq E, Balzarini J, Dimmock JR (2007) Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis (arylidene)-4-piperidones and related compounds. Eur J Med Chem 42:71-80. doi:10.1016/j.ejmech.2006.08.002 (Pubitemid 46198985)
6. Dhillon N, Wolf RA, Abbruzzese JL, Hong DS, Camacho LH, Li L, Braiteh FS, Kurzrock R (2006) Phase II clinical trial of curcumin in patients with advanced pancreatic cancer. J Clin Oncol 24:14151
7. +-dependent DNA ligase (Rv3014c) from M. tuberculosis: strategies for inhibitor design. Med Chem Res 17:189-198. doi:10.1007/s00044-007-9052-5
8. Fadda AA, Badria FA, El-Attar KM (2009) Synthesis and evaluation of curcumin analogues as cytotoxic agents. Med Chem Res. doi: 10.1007/s00044-009- 9199-3
9. Gafner SK, Lee SK, Cuendet M, Barthelemy S, Vergnes L, Labidalle S, Mehta RG, Boone CW, Pezzuto JM (2004) Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 65:2849-2859. doi:10.1016/j.phttochem.2004.08.008 (Pubitemid 40292116)
10. Jing-yan T, Guo L, Yan-yun G, Hong-li Z, Wen-zhong Z, Xiao W, Hong-da Z, Tian-hong L, Min L (2006) Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty acids on isolated rat islets. Chin Med 119(7):574-580
11. Karunagaran D, Rashmi R, Kumar TR (2005) Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Target 5:117-129. doi:10.2174/1568009053202081 (Pubitemid 40488598)
12. Lakshmi S, Dhanya GS, Joy B, Padmaja G, Remani P (2008) Inhibitory effect of an extract of Curcuma zedoariae on human cervical carcinoma cells. Med Chem Res 17:335-344. doi:10.1007/s00044-007-9069-9
13. Li N, Cehn X, Liao J, Yang G, Wang S, Jossephson Y, Han C, Chen J, Huang MT, Yang CS (2002) Inhibiton of 7,12-dimethylbenz[ a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23:1307-1313. doi:10.1093/carcin/23.8.1307
14. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H (2008a) Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 18:1525-1529. doi:10.1016/j.bmcl.2007.12.068 (Pubitemid 351226515)
15. Liang G, Yang S, Jiang L, Zhao Y, Shao L, Xiao J, Ye F, Li Y, Li X (2008b) Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chem Pharm Bull 56(2):162-167. doi:10.1248/cpb.56.162 (Pubitemid 351206638)
16. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S (1995) Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem 59:1609-1612 PMID: 8520105
17. Panchatcharam M, Miriyala S, Gayathri VS, Suguna L (2006) Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem 290:87-96. doi:10.1007/s11010-006-9170-2 (Pubitemid 44473238)
18. PatchDock Server (2008) An automatic server for molecular docking. http://bioinfo3d.cs.tau.ac.il/PatchDock/
19. Pati HN, Das U, Quail JW, Kawase M, Sakagami H, Dimmock JR (2008) Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Eur J Med Chem 43:1-7. doi:10.1016/j.ejmech.2007.03.010
20. Pati HN, Das U, Das S, Bandy B, Clercq ED, Balzarini J, Kawase M, Sakagami H, Quail JW, Stables PJ, Dimmock JR (2009) The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8- methyl-8-azabicyclo [3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4- piperidones. Eur J Med Chem 44:54-62. doi:10.1016/j.ejmech.2008.03.015
21. RCSB Protein Data Bank. Solution structure of the catalytic domain of mapk phosphatase pac-1: insights into substrate-induced enzymatic activation. Receptor 1m3g available at http://www.rcsb.org/pdb/explore/explore.do? structureId=1M3G
22. Santo RD, Costi R, Artico M, Ragno R, Greco G, Novellino E, Marchand C, Pommier Y (2005) Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. IL Farmaco 60:409-417. doi:10.1016/j.farmac.2005. 03.008 (Pubitemid 40731526)
23. Wu J, Jin YJ, Calaf GM, Huang WL, Yin Y (2007) PAC1 is a direct transcription target of E2F-1 in apoptotic signaling. Oncogene 26(45):6526-6535. doi:10.1038/sj.onc.1210484 (Pubitemid 47530605)
24. Zeng JH, Xu GB, Chen X (2009) Application of the chromatograhic fingerprint for quality control of essential oil from GuangXi Curcuma kwangsiensis. Med Chem Res 18:158-165. doi:10.1007/s00044-008-9115-2